ESR1 and prostate cancer: In summary, using endothelial HAECs and prostate cancer LAPC-4 and LNCaP cells as the model system, we have demonstrated that DHT-induced cell proliferation and gene expression are differentially modulated by ER ligands in a cell-specific manner.